繁體
简体中文
繁體中文

Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst TOIIW 深 滬

已收盤 08-05 16:00:00 美东时间

0.049

0.000

0.00%

华盛通華盛通
立即下載
  • 最 高--
  • 今 開--
  • 成交量 0股
  • 最 低 --
  • 昨 收 0.049
  • 總市值 0
  • 52周最高 0.2725
  • 市盈率 靜 --
  • 換手率 NaN.00%
  • 52周最低 0.025
  • 委 比 0.00%
  • 總股本 --
  • 歷史最高 3.86
  • 量 比 0
  • 振 幅 0.00%
  • 歷史最低 0.00
  • 每 手 1
  • 風險率 0.05%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

    Starling Oncology, Inc. (NASDAQ: STLN) announced it will release its third quarter 2026 financial results on November 5, 2026, followed by a conference call at 5:00 p.m. ET. The call can be accessed via phone or webcast, with replay available for two weeks. Founded in 2007, Starling Oncology provides specialized cancer care to over 2.2 million patients through 100+ clinics across five states.

    10-26 13:00

  • Full Transcript: Oncology Institute Q2 2026 Earnings Call

    Oncology Institute (NASDAQ:TOI) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a con...

    10-13 16:36

  • Starling Oncology to Participate in Wells Fargo Healthcare Conference

    Starling Oncology, Inc. (NASDAQ: STLN), a leading value-based community oncology group in the U.S., announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the Wells Fargo Healthcare Conference in Boston on September 8, 2026. They will engage in a fireside chat from 4:30–5:05 p.m. ET. A webcast of the presentation will be available on the Company’s Investor Relations website. Starling Oncology, founded in 2007, provides speci...

    08-24 13:00

  • Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale

    Starling Oncology launched Starling Oncology Nexus, a proprietary platform addressing challenges in cancer care compliance and prior authorization. The platform streamlines oncology workflows by integrating clinical decision support, evidence-based pathways, and utilization management, reducing administrative burdens and improving patient care. It also connects ancillary services like pharmacy and clinical trials, aiming to enhance coordination a...

    08-17 12:00

  • The Oncology Institute Q2 EPS $(0.08) Misses $(0.06) Estimate, Sales $161.282M Beat $155.193M Estimate

    The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $161.2...

    08-07 05:28

  • Starling Oncology Unveils New Nasdaq Ticker Symbol

    Oncology Institute ( ($TOI) ) has shared an announcement. In late July 2026, Th...

    08-03 21:54

  • The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call

    The Oncology Institute, Inc. (TOI) announced it will release its second quarter 2026 financial results on August 6, 2026, followed by a conference call at 5:00 p.m. Eastern Time. The call can be accessed via phone using the provided numbers and Conference ID: TOI, or through a webcast on the company’s Investor Relations website. A replay will be available three hours after the call until August 20, 2026. TOI, a leader in value-based oncology care...

    07-27 13:00

  • BTIG’s top small and mid-cap stocks for H2, ranked by SA Quant

    BTIG analysts selected their favorite stock picks over a 12-month investment period within the small- and mid-cap space for the second half of the year. These are BTIG’s highest conviction investment ...

    07-02 00:32